| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Venus Concept Inc. | VP, RA/QA/Clinical Affairs | Common Stock | 5,181 | $1,260 | $0.2431 | 07 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERO | Venus Concept Inc. | 07 Feb 2023 | 0 | $0 | 4 | VP, RA/QA/Clinical Affairs | 07 Feb 2023, 15:39 |
| VERO | Venus Concept Inc. | 10 Nov 2022 | 1 | $0 | 4 | VP, RA/QA/Clinical Affairs | 14 Nov 2022, 16:46 |
| VERO | Venus Concept Inc. | 25 Mar 2022 | 2 | $0 | 4 | VP Scientific Affairs | 28 Mar 2022, 14:38 |
| VERO | Venus Concept Inc. | 18 Aug 2021 | 1 | $10,051 | 4 | VP, RA/QA/Clinical Affairs | 20 Aug 2021, 19:19 |
| VERO | Venus Concept Inc. | 18 Aug 2021 | 1 | $0 | 4 | VP, RA/QA/Clinical Affairs | 20 Aug 2021, 16:15 |